Figure 1
From: Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
Effect of telmisartan and losartan on measures of glycaemia and insulin resistance in 40 patients with metabolic syndrome. FPG = fasting plasma glucose, FPI = fasting plasma insulin, HOMA-IR = homeostatic model assessment – insulin resistance, HbA1c = glycosylated haemoglobin.
